VF
CTOR

Virtu Financial’s Citius Oncology CTOR Stock Holding History

Virtu Financial’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,291
Closed -$14K – 2187
2024
Q3 		$14K Sell
10,291
-17,817
-63% -$126K ﹤0.01% 1166
2024
Q2 		$319K Sell
28,108
-426
-1% -$4.78K 0.02% 581
2024
Q1 		$316K Buy
+28,534
New +$314K 0.02% 597
2023
Q4 		– Sell
-12,128
Closed -$130K – 2092
2023
Q3 		$130K Sell
12,128
-30,290
-71% -$323K 0.01% 771
2023
Q2 		$447K Buy
42,418
+32,068
+310% +$335K 0.03% 435
2023
Q1 		$108K Buy
+10,350
New +$106K 0.01% 958

Other funds holding CTOR

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Virtu Financial's CTOR Position: Q4 2024 in Review

Virtu Financial sold out of Citius Oncology (CTOR) in Q4 2024, closing a stake of 10,291 shares — an estimated $14K sold.

Virtu Financial first reported a position in CTOR in Q1 2023 and held it in 6 quarters. The position peaked at $447K in Q2 2023. 11 funds tracked by Wall St. Rank hold CTOR as of Q4 2024.

  • Virtu Financial reported no remaining Citius Oncology position as of Q4 2024 after selling out during the quarter.
  • Virtu Financial sold 10,291 Citius Oncology shares in Q4 2024, an estimated $14K.
  • Virtu Financial first reported a position in Citius Oncology in Q1 2023 and held it in 6 quarters.
  • Virtu Financial's Citius Oncology position peaked at $447K in Q2 2023.
  • 11 funds tracked by Wall St. Rank held Citius Oncology as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.